In a cohort of 72 patients with MDS, 15 (20.8%) tested positive for FLT3 internal tandem duplication (FLT3-ITD) and showed significantly inferior OS and PFS compared to those without the mutation [103]. This evidence concerns the gene FLT3 and myelodysplastic syndrome.